[Metabolic disorders as paraneoplastic syndromes]

Area of Science:

• Oncology
• Endocrinology
• Internal Medicine

Background:

• Paraneoplastic syndromes involve tumor-driven hormone release or immune responses.
• Metabolic alterations are critical, often presenting acutely and requiring immediate intervention.
• These syndromes cause clinical and lab changes independent of tumor burden.

Purpose of the Study:

• To review diagnostic and therapeutic strategies for metabolic disorders in paraneoplastic syndromes.
• To highlight the importance of multidisciplinary and intensive care unit management.
• To cover specific metabolic issues including hypercalcemia, hypocalcemia, hyperglycemia, hypoglycemia, and tumor lysis syndrome.

Main Methods:

• Literature review focusing on diagnostic and therapeutic options.
• Analysis of metabolic alterations associated with paraneoplastic syndromes.
• Discussion of emergency presentation and management protocols.

Main Results:

• Metabolic disorders are common, acute presentations of paraneoplastic syndromes.
• Prompt diagnosis and multidisciplinary treatment are essential.
• Specific conditions discussed include hypercalcemia, hypocalcemia, hyperglycemia, hypoglycemia, and tumor lysis syndrome.

Conclusions:

• Metabolic alterations are a significant clinical challenge in paraneoplastic syndromes.
• Integrated, multidisciplinary management, often in ICUs, is necessary.
• Effective diagnostic and therapeutic approaches are vital for patient outcomes.